An objective evaluation of the treatment of systemic scleroderma with disodium EDTA, pyridoxine and reserpine.
D000328:Adult; D004492:Edetic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011736:Pyridoxine / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D012110:Reserpine; D004492:Edetic Acid; D011736:Pyridoxine